Search research articles
Contact Us
Filters
Showing results (61-70 of 95) with videos related to
Page
of 10
Sort By:
The Journal of Clinical Endocrinology and Metabolism
|
July 7, 2005
Severe congenital hyperinsulinism caused by a mutation in the Kir6.2 subunit of the adenosine triphosphate-sensitive potassium channel impairing trafficking and function
Eric Marthinet, Alain Bloc, Yoshimoto Oka, et al.
International Journal of Molecular Sciences
|
November 11, 2022
Gsk-3-Mediated Proteasomal Degradation of ATF4 Is a Proapoptotic Mechanism in Mouse Pancreatic β-Cells
Yuko Nagao, Kikuko Amo-Shiinoki, Hiroko Nakabayashi, et al.
Communications Biology
|
May 7, 2024
E4BP4 in macrophages induces an anti-inflammatory phenotype that ameliorates the severity of colitis
Yasuko Kajimura, Akihiko Taguchi, Yuko Nagao, et al.
Annals of Hematology
|
May 23, 2022
Significance of alveolar nitric oxide concentration in the airway of patients with organizing pneumonia after allogeneic hematopoietic stem cell transplantation
Yasuko Kajimura, Yukinori Nakamura, Tsunahiko Hirano, et al.
Diabetes Research and Clinical Practice
|
January 31, 2006
A novel mutation of WFS1 gene in a Japanese man of Wolfram syndrome with positive diabetes-related antibodies
Akinobu Nakamura, Chikara Shimizu, So Nagai, et al.
Peptides
|
October 13, 2004
Genetic variations at urotensin II and urotensin II receptor genes and risk of type 2 diabetes mellitus in Japanese
Susumu Suzuki, Zong Wenyi, Masashi Hirai, et al.
Biochemical and Biophysical Research Communications
|
March 18, 2008
Identification of Glypican3 as a novel GLUT4-binding protein
Akihiko Taguchi, Masahiro Emoto, Shigeru Okuya, et al.
Cardiovascular Diabetology
|
April 1, 2014
Efficacy and safety of monotherapy with the novel sodium/glucose cotransporter-2 inhibitor tofogliflozin in Japanese patients with type 2 diabetes mellitus: a combined Phase 2 and 3 randomized, placebo-controlled, double-blind, parallel-group comparative study
Kohei Kaku, Hirotaka Watada, Yasuhiko Iwamoto, et al.
Expert Opinion on Pharmacotherapy
|
February 12, 2014
Long-term safety and efficacy of tofogliflozin, a selective inhibitor of sodium-glucose cotransporter 2, as monotherapy or in combination with other oral antidiabetic agents in Japanese patients with type 2 diabetes mellitus: multicenter, open-label, randomized controlled trials
Yukio Tanizawa, Kohei Kaku, Eiichi Araki, et al.
Ebiomedicine
|
April 9, 2017
Clock Gene Dysregulation Induced by Chronic ER Stress Disrupts β-cell Function
Yasuharu Ohta, Akihiko Taguchi, Takuro Matsumura, et al.
Page
of 10
Search research articles
Search
Showing results (61-70 of 95) with videos related to
Sort By:
Page
of 10
The Journal of Clinical Endocrinology and Metabolism
|
July 7, 2005
Severe congenital hyperinsulinism caused by a mutation in the Kir6.2 subunit of the adenosine triphosphate-sensitive potassium channel impairing trafficking and function
Eric Marthinet, Alain Bloc, Yoshimoto Oka, et al.
International Journal of Molecular Sciences
|
November 11, 2022
Gsk-3-Mediated Proteasomal Degradation of ATF4 Is a Proapoptotic Mechanism in Mouse Pancreatic β-Cells
Yuko Nagao, Kikuko Amo-Shiinoki, Hiroko Nakabayashi, et al.
Communications Biology
|
May 7, 2024
E4BP4 in macrophages induces an anti-inflammatory phenotype that ameliorates the severity of colitis
Yasuko Kajimura, Akihiko Taguchi, Yuko Nagao, et al.
Annals of Hematology
|
May 23, 2022
Significance of alveolar nitric oxide concentration in the airway of patients with organizing pneumonia after allogeneic hematopoietic stem cell transplantation
Yasuko Kajimura, Yukinori Nakamura, Tsunahiko Hirano, et al.
Diabetes Research and Clinical Practice
|
January 31, 2006
A novel mutation of WFS1 gene in a Japanese man of Wolfram syndrome with positive diabetes-related antibodies
Akinobu Nakamura, Chikara Shimizu, So Nagai, et al.
Peptides
|
October 13, 2004
Genetic variations at urotensin II and urotensin II receptor genes and risk of type 2 diabetes mellitus in Japanese
Susumu Suzuki, Zong Wenyi, Masashi Hirai, et al.
Biochemical and Biophysical Research Communications
|
March 18, 2008
Identification of Glypican3 as a novel GLUT4-binding protein
Akihiko Taguchi, Masahiro Emoto, Shigeru Okuya, et al.
Cardiovascular Diabetology
|
April 1, 2014
Efficacy and safety of monotherapy with the novel sodium/glucose cotransporter-2 inhibitor tofogliflozin in Japanese patients with type 2 diabetes mellitus: a combined Phase 2 and 3 randomized, placebo-controlled, double-blind, parallel-group comparative study
Kohei Kaku, Hirotaka Watada, Yasuhiko Iwamoto, et al.
Expert Opinion on Pharmacotherapy
|
February 12, 2014
Long-term safety and efficacy of tofogliflozin, a selective inhibitor of sodium-glucose cotransporter 2, as monotherapy or in combination with other oral antidiabetic agents in Japanese patients with type 2 diabetes mellitus: multicenter, open-label, randomized controlled trials
Yukio Tanizawa, Kohei Kaku, Eiichi Araki, et al.
Ebiomedicine
|
April 9, 2017
Clock Gene Dysregulation Induced by Chronic ER Stress Disrupts β-cell Function
Yasuharu Ohta, Akihiko Taguchi, Takuro Matsumura, et al.
Page
of 10